270 related articles for article (PubMed ID: 27317256)
1. Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.
Gharbaran R
Tumour Biol; 2016 Sep; 37(9):11573-11588. PubMed ID: 27317256
[TBL] [Abstract][Full Text] [Related]
2. Syndecans in chronic inflammatory and autoimmune diseases: Pathological insights and therapeutic opportunities.
Agere SA; Kim EY; Akhtar N; Ahmed S
J Cell Physiol; 2018 Sep; 233(9):6346-6358. PubMed ID: 29226950
[TBL] [Abstract][Full Text] [Related]
3. Shedding light on the distinct functions of proteoglycans.
Selleck SB
Sci STKE; 2006 Apr; 2006(329):pe17. PubMed ID: 16595733
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
[TBL] [Abstract][Full Text] [Related]
5. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
[TBL] [Abstract][Full Text] [Related]
6. The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity.
Filla MS; Dam P; Rapraeger AC
J Cell Physiol; 1998 Mar; 174(3):310-21. PubMed ID: 9462693
[TBL] [Abstract][Full Text] [Related]
7. Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies.
Gharbaran R
Crit Rev Oncol Hematol; 2015 Apr; 94(1):1-17. PubMed ID: 25563413
[TBL] [Abstract][Full Text] [Related]
8. Testosterone-induced growth of S115 mouse mammary tumor cells is dependent on heparan sulfate.
Borgenström M; Tienhaara A; Spillmann D; Salmivirta M; Jalkanen M
Exp Cell Res; 2001 Apr; 264(2):307-14. PubMed ID: 11262187
[TBL] [Abstract][Full Text] [Related]
9. Syndecan-1 in B lymphoid malignancies.
Sanderson RD; Børset M
Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
Chiodelli P; Mitola S; Ravelli C; Oreste P; Rusnati M; Presta M
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e116-27. PubMed ID: 21921258
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulphate proteoglycan expression in human primary liver tumours.
Roskams T; De Vos R; David G; Van Damme B; Desmet V
J Pathol; 1998 Jul; 185(3):290-7. PubMed ID: 9771483
[TBL] [Abstract][Full Text] [Related]
12. Signaling from across the way: transactivation of VEGF receptors by HSPGs.
Selleck SB
Mol Cell; 2006 May; 22(4):431-2. PubMed ID: 16713570
[TBL] [Abstract][Full Text] [Related]
13. VEGF: an essential mediator of both angiogenesis and endochondral ossification.
Dai J; Rabie AB
J Dent Res; 2007 Oct; 86(10):937-50. PubMed ID: 17890669
[TBL] [Abstract][Full Text] [Related]
14. Syndecans as modulators and potential pharmacological targets in cancer progression.
Barbouri D; Afratis N; Gialeli C; Vynios DH; Theocharis AD; Karamanos NK
Front Oncol; 2014; 4():4. PubMed ID: 24551591
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration.
Cornelison DD; Filla MS; Stanley HM; Rapraeger AC; Olwin BB
Dev Biol; 2001 Nov; 239(1):79-94. PubMed ID: 11784020
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
17. Syndecans in angiogenesis and endothelial cell biology.
De Rossi G; Whiteford JR
Biochem Soc Trans; 2014 Dec; 42(6):1643-6. PubMed ID: 25399583
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
Eppler E; Janas E; Link K; Weidmann L; Bischofberger H; Wenger M; Tinguely M; Schraml P; Moch H; Fellbaum C
Cell Tissue Res; 2015 Mar; 359(3):841-51. PubMed ID: 25487403
[TBL] [Abstract][Full Text] [Related]
19. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
[TBL] [Abstract][Full Text] [Related]
20. Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes.
Bansal R; Kumar M; Murray K; Pfeiffer SE
Mol Cell Neurosci; 1996 Apr; 7(4):276-88. PubMed ID: 8793863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]